FORCE REPAIR – 4th Progress Meeting

November 26, 2024

Last week the 4th Progress meeting of the EU-funded project RBDCOV was held in Barcelona.

 

The FORCE REPAIR project aims to develop a smart, multi-functional and cost-effective 3D-printed wound dressing to help control bacterial infection and inflammation, and aid tissue regeneration.

 

ASPHALION is a proud FORCE REPAIR partner and leader of the regulatory work package, which aims to establish the regulatory pathway for the innovative wound dressing and ensure the manufacturing process complies with regulatory requirements.

 

  • ASPHALION experts Jon Giblin and Montse Domingo attended the meeting, providing an update on plans for future interactions with regulators to ensure validation of the proposed regulatory pathway.

 

  • The meeting also featured a Regulatory and Exploitation Workshop led by Jon Giblin from ASPHALION and Ivana Vuka from RISE – Research and Innovation Services. This workshop introduced key concepts and created general regulatory awareness in early development to facilitate the timely transition of a 3D printed multifunctional wound dressing to clinical trials and beyond

 

ASPHALION would like to give a big thank you all participants and partners who showcased the great progress made in the past months. It was a pleasure to host you all here in Barcelona and we look forward to the next meeting.

Need help in your EU-funded projects or regulatory endeavours? Contact us at: [email protected]

The FORCE REPAIR project is funded by the European Union under grant agreement No. 101092243, as part of the Horizon Europe Framework Programme (HORIZON). It represents a collaboration between 14 partners from academia and Small and Medium Enterprises (SMEs).

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting